Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes
Clinical trial NCT02670915 · COMPLETED
Trial details
- NCT number
- NCT02670915
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-04
- Primary completion
- 2018-02-05
- Enrollment
- 834
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.